Phosphorylation-directed antibodies in high-flux screens for compounds that modulate signal transduction

BioTechniques

Volumn 23, Issue 3, 1997, Pages 490-493

  Alberta, John A ^a   Stiles, Charles D ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GROWTH FACTOR RECEPTOR; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN; SYNTHETIC PEPTIDE;

ANTIBODY PRODUCTION; ARTICLE; COLORIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 0030967777     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/97233st07     Document Type: Article

References (25)

1. Akiyama, T., S. Matsuda, Y. Namba, T. Saito, K. Toyoshima and T. Yamaoto. 1991. The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain. Mol. Cell Biol. 11:833-842.
2. Bangalore, L., A.J. Tanner, A.P. Laudano and D.F. Stern. 1992. Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 89:11637-11641.
3. Ben-Levy, R.B., H.F. Paterson, C.J. Marshall and Y. Yarden. 1994. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J. 13:3302-3311.
4. Berger, M.S., G.W. Locher, S. Saurer, W.J. Gullick, M.D. Waterfield, B. Groner and N.E. Hynes. 1988. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 48:1238-1243.
5. Campbell, K.S., O. Ogris, B. Burke, W. Su, K.R. Auger, B.J. Druker, B.S. Schaffhausen, T.M. Roberts and D.C. Pallas. 1994. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA 91:6344-6348.
6. Cao, H., S. Decker and D.F. Stern. 1991. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro. Oncogene 6:705-711.
7. Claesson-Welsh, L. 1994. Platelet-derived growth factor receptor signals. [Review] J. Biol. Chem. 269:32023-32026.
8. Dilworth, S.M., C.E.P. Brewster, M.D. Jonew, L. Lanfrancone, G. Pelicci and P.G. Pelicci. 1994. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of She. Nature 367:87-90.
9. Epstein, R.J., B.J. Druker, T.M. Roberts and C.D. Stiles. 1990. Modulation of a Mr 175,000 c-neu receptor isoform in G8/DHFR cells by serum starvation. J. Biol. Chem. 265:10746-10751.
10. Epstein, R.J., B.J. Druker, T.M. Roberts and C.D. Stiles. 1992. Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor. Proc. Natl. Acad. Sci. USA 89:10435-10439.
11. Ginty, D.D., J.M. Kornhauser, M.A. Thompson, H. Bading, K.E. Mayo, J.S. Takahashi and M.E. Greenberg. 1993. Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science 260:238-241.
12. Hagiwara, M., P. Brindle, A. Harootunian, R. Armstrong, J. Rivier, W. Vale, R. Tsien and M.R. Montminy. 1993. Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol. Cell. Biol. 13:4852-4859.
13. Harlow, E. and D. Lane. 1988. Antibodies: A Laboratory Manual. CSH Laboratory Press, Cold Spring Harbor, NY.
14. Hubbard, S.R., L. Wei, L. Ellis and W.A. Kendrickson. 1994. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372:746-754.
15. Hung, M.C., A.L. Schechter, P.Y. Chevray, D.F. Stern and R.A. Weinberg. 1986. Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc. Natl. Acad. Sci. USA 83:261-264.
16. Hunter, T. 1987. A thousand and one protein kinases. [Review] Cell 50:823-829.
17. Hunter, T., R.A. Lindberg, D.S. Middlemas, S. Tracy and P. van der Geer. 1992. Receptor protein tyrosine kinases and phosphatases. [Review] Cold Spring Harb. Symp. Quant. Biol. 57:25-41.
18. Margolis, B.L., I. Lax, R. Kris, M. Dombalagian, A.M. Honegger, R. Howk, D. Givol, A. Ullrich and J. Schlessinger. 1989 All autophosphorylalion sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. J. Biol. Chem. 264:10667-10671.
19. Mikami, Y., J.G. Davis, K. Dobashi, W.C. Dougall, J.N. Myers, V.I. Brown and M.I. Greene. 1992. Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product. Proc. Natl. Acad. Sci. USA 89:7335-7339.
20. Saito, T., K. Ishiguro, T. Uchida, E. Miyamoto, T. Kishimoto and S. Hisanaga. 1995. In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. FEBS Lett. 376:238-242.
21. Segatto, O., F. Lonardo, J.H. Pierce, D.P. Bottaro and P.P. DiFiore. 1990. The role of amophosphorylation in modulation of erbB-2 transforming function. New Biol. 2:187-195.
22. Slamon, D.J., G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich and W.L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
23. Towbin, H., T. Staehelin and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
24. White, M.F. 1991. Structure and function of tyrosine kinase receptors. [Review] J. Bioenerg. Biomembr. 23:63-82.
25. Yon, M., P. White and N. Groome. 1995. Preparation of a novel monoclonal antibody specific for myelin basic protein phosphorylated on Thr98. J. Neuroimmunol. 58:121-129.